289 related articles for article (PubMed ID: 8782014)
1. Viral resistance: a major challenge in managing HIV disease.
Boucher CA; Reedijk M
J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
[No Abstract] [Full Text] [Related]
2. [New trends in HIV].
Volkert R
Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
[No Abstract] [Full Text] [Related]
3. Two studies suggest nevirapine benefit for children.
AIDS Patient Care STDS; 1997 Jun; 11(3):195. PubMed ID: 11361798
[No Abstract] [Full Text] [Related]
4. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
[TBL] [Abstract][Full Text] [Related]
5. Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy.
Batisse D; Karmochkine M; Si Mohamed A; Piketty C; Kazatchkine MD; Belec L
AIDS; 1998 May; 12(7):824-5. PubMed ID: 9619820
[No Abstract] [Full Text] [Related]
6. [Nevirapine: a new principle of action against HIV].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915
[No Abstract] [Full Text] [Related]
7. Update on nevirapine: quest for a niche.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713
[TBL] [Abstract][Full Text] [Related]
8. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
9. Salvage therapy for patients failing their current antiretroviral regimen.
Albrecht MA
AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
[No Abstract] [Full Text] [Related]
10. Multi-drug resistant HIV-1.
Omrani AS; Pillay D
J Infect; 2000 Jul; 41(1):5-11. PubMed ID: 10942635
[No Abstract] [Full Text] [Related]
11. HIV resistance testing proves its value.
Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoresistance: an emerging clinical problem.
Carosi G
J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
[No Abstract] [Full Text] [Related]
14. Resistance of HIV to antiretroviral agents. Basic concepts.
Dianzani F; Antonelli G; Turriziani O
J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):19-22. PubMed ID: 9689574
[No Abstract] [Full Text] [Related]
15. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
Hecht FM; Grant RM; Petropoulos CJ; Dillon B; Chesney MA; Tian H; Hellmann NS; Bandrapalli NI; Digilio L; Branson B; Kahn JO
N Engl J Med; 1998 Jul; 339(5):307-11. PubMed ID: 9682043
[No Abstract] [Full Text] [Related]
16. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
[TBL] [Abstract][Full Text] [Related]
17. Nevirapine approval expands combo possibilities--and HIV suppression.
Vazquez E
Posit Aware; 1996; 7(5):9. PubMed ID: 11363791
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy in human immunodeficiency virus-infected individuals.
Spooner KM
Adv Intern Med; 1998; 43():373-402. PubMed ID: 9506188
[No Abstract] [Full Text] [Related]
19. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
20. [Human immunodeficiency virus and antiretroviral therapy resistance].
Quirós E; Torti C; Carosi G
Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
